New England Journal of Medicine · 1984 · 1.7K citations · 17 references
Life SciencesCardiologyHematologyHemostasisPathophysiologyRisk Factor AnalysisCardiovascular DiseaseCardiovascular PathophysiologyCardiovascular RiskCerebrovascular DiseaseCoagulation PhysiologyStrokeBlood PressureFibrinogen InfluencePlasma Cholesterol Levels
Fibrinogen may play an important role in the development of stroke and myocardial infarction, though causality cannot be inferred from these data. The study aimed to identify risk factors for cardiovascular disease in a random sample of 792 men aged 54. Researchers measured plasma coagulation factors, blood pressure, serum cholesterol, and smoking status at baseline and followed participants for 13.5 years, during which 92 myocardial infarctions and 37 strokes occurred. Baseline blood pressure, smoking, serum cholesterol, and fibrinogen were significant risk factors for infarction, while blood pressure and fibrinogen were risk factors for stroke; fibrinogen remained significantly associated with stroke even after adjusting for other variables, and fibrinogen and smoking were strongly correlated. (N Engl J Med 1984; 311:501–5.).
To study the possible risk factors for cardiovascular disease, we collected data on plasma levels of coagulation factors, blood pressure, serum cholesterol, and smoking in a random sample of 792 men 54 years of age. During 13.5 years of follow-up, myocardial infarction occurred in 92 men, stroke in 37, and death from causes other than myocardial infarction or stroke in 60. The blood pressure, degree of smoking, serum cholesterol, and fibrinogen level measured at the base-line examination proved to be significant risk factors for infarction by univariate analyses during follow-up, and blood pressure and fibrinogen were risk factors for stroke. Fibrinogen and smoking were strongly related to each other. The relation between fibrinogen and infarction, and between fibrinogen and stroke, became weaker when blood pressure, serum cholesterol, and smoking habits were taken into account, but was still significant for stroke. Although causality cannot be inferred from these data, it is possible that the fibrinogen level plays an important part in the development of stroke and myocardial infarction. (N Engl J Med 1984; 311:501–5.)
17
HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY
T W Meade, Ranjan Chakrabarti, Andy Haines et al. · The Lancet · 1980 · 697 citations
Controlled trial of aspirin in cerebral ischemia.
William S. Fields, Noreen A. Lemak, Ralph F. Frankowski et al. · Stroke · 1977 · 634 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
William S. Fields, Noreen A. Lemak, Ralph F. Frankowski et al. · Stroke · 1978 · 172 citations · Full text
Medicine, Neurology, Pharmacotherapy +17